These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10780708)

  • 1. Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men.
    Lampinen TM; Critchlow CW; Kuypers JM; Hurt CS; Nelson PJ; Hawes SE; Coombs RW; Holmes KK; Kiviat NB
    AIDS; 2000 Mar; 14(5):F69-75. PubMed ID: 10780708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.
    Cu-Uvin S; Caliendo AM; Reinert S; Chang A; Juliano-Remollino C; Flanigan TP; Mayer KH; Carpenter CC
    AIDS; 2000 Mar; 14(4):415-21. PubMed ID: 10770544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy.
    Galli M; Balotta C; Meroni L; Colombo MC; Papagno L; Bagnarelli P; Testa L; Varchetta S; Colombo L; Moroni M; d'Arminio Monforte A; Clerici M; Clementi M
    AIDS; 1998 Dec; 12(18):2500-2. PubMed ID: 9875591
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay.
    Désiré N; Dehée A; Schneider V; Jacomet C; Goujon C; Girard PM; Rozenbaum W; Nicolas JC
    J Clin Microbiol; 2001 Apr; 39(4):1303-10. PubMed ID: 11283046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children.
    Saitoh A; Hsia K; Fenton T; Powell CA; Christopherson C; Fletcher CV; Starr SE; Spector SA
    J Infect Dis; 2002 May; 185(10):1409-16. PubMed ID: 11992275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients.
    Ibáñez A; Puig T; Elias J; Clotet B; Ruiz L; Martínez MA
    AIDS; 1999 Jun; 13(9):1045-9. PubMed ID: 10397534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy.
    Andreoni M; Parisi SG; Sarmati L; Nicastri E; Ercoli L; Mancino G; Sotgiu G; Mannazzu M; Trevenzoli M; Tridente G; Concia E; Aceti A
    AIDS; 2000 Jan; 14(1):23-9. PubMed ID: 10714564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy.
    Zuckerman RA; Whittington WL; Celum CL; Collis TK; Lucchetti AJ; Sanchez JL; Hughes JP; Sanchez JL; Coombs RW
    J Infect Dis; 2004 Jul; 190(1):156-61. PubMed ID: 15195255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection.
    Lillo FB; Ciuffreda D; Veglia F; Capiluppi B; Mastrorilli E; Vergani B; Tambussi G; Lazzarin A
    AIDS; 1999 May; 13(7):791-6. PubMed ID: 10357377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.
    Zhang H; Dornadula G; Beumont M; Livornese L; Van Uitert B; Henning K; Pomerantz RJ
    N Engl J Med; 1998 Dec; 339(25):1803-9. PubMed ID: 9854115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects.
    Anton PA; Mitsuyasu RT; Deeks SG; Scadden DT; Wagner B; Huang C; Macken C; Richman DD; Christopherson C; Borellini F; Lazar R; Hege KM
    AIDS; 2003 Jan; 17(1):53-63. PubMed ID: 12478069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group.
    Notermans DW; Jurriaans S; de Wolf F; Foudraine NA; de Jong JJ; Cavert W; Schuwirth CM; Kauffmann RH; Meenhorst PL; McDade H; Goodwin C; Leonard JM; Goudsmit J; Danner SA
    AIDS; 1998 Jan; 12(2):167-73. PubMed ID: 9468365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens.
    Ghosn J; Leruez-Ville M; Blanche J; Delobelle A; Beaudoux C; Mascard L; Lecuyer H; Canestri A; Landman R; Zucman D; Ponscarme D; Rami A; Viard JP; Spire B; Rouzioux C; Costagliola D; Suzan-Monti M;
    Clin Infect Dis; 2014 Jun; 58(12):1763-70. PubMed ID: 24647014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.
    Cavert W; Notermans DW; Staskus K; Wietgrefe SW; Zupancic M; Gebhard K; Henry K; Zhang ZQ; Mills R; McDade H; Schuwirth CM; Goudsmit J; Danner SA; Haase AT
    Science; 1997 May; 276(5314):960-4. PubMed ID: 9139661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons.
    Bruisten SM; Reiss P; Loeliger AE; van Swieten P; Schuurman R; Boucher CA; Weverling GJ; Huisman JG
    AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1053-8. PubMed ID: 9718120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
    Clark NM; Dieng Sarr A; Sankalé JL; Kanki PJ; Kazanjian P; Winfield R; Markovitz DM
    AIDS; 1998 Dec; 12(18):2506-7. PubMed ID: 9875594
    [No Abstract]   [Full Text] [Related]  

  • 17. High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy.
    Jubault V; Burgard M; Le Corfec E; Costagliola D; Rouzioux C; Viard JP
    AIDS; 1998 Dec; 12(17):2358-9. PubMed ID: 9863885
    [No Abstract]   [Full Text] [Related]  

  • 18. The HYDILE trial: efficacy and tolerance of a quadruple combination of reverse transcriptase inhibitors versus the same regimen plus hydroxyurea or hydroxyurea and interleukin-2 in HIV-infected patients failing protease inhibitor-based combinations.
    Lafeuillade A; Hittinger G; Chadapaud S; Maillefet S; Rieu A; Poggi C
    HIV Clin Trials; 2002; 3(4):263-71. PubMed ID: 12187499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid decay of HIV RNA in the cerebrospinal fluid during antiretroviral combination therapy.
    Stellbrink HJ; Eggers C; van Lunzen J; Albrecht H; Greten H
    AIDS; 1997 Nov; 11(13):1655-7. PubMed ID: 9365775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.